Merck Manual

Please confirm that you are a health care professional

honeypot link

Lymphocytic Interstitial Pneumonia

(Lymphoid Interstitial Pneumonitis)


Joyce Lee

, MD, MAS, University of Colorado School of Medicine

Last full review/revision Jun 2021| Content last modified Jun 2021
Click here for Patient Education
Topic Resources

Lymphocytic interstitial pneumonia (LIP) is lymphocytic infiltration of the alveolar interstitium and air spaces. The cause is unknown. Symptoms and signs are cough, progressive dyspnea, and crackles. Diagnosis is based on history, physical examination, imaging tests, and lung biopsy. Treatment is with corticosteroids, cytotoxic drugs, or both, although efficacy is unknown. Five-year survival is 50 to 66%.

Lymphocytic interstitial pneumonia is a rare idiopathic interstitial pneumonia Overview of Idiopathic Interstitial Pneumonias Idiopathic interstitial pneumonias (IIPs) are interstitial lung diseases of unknown etiology that share similar clinical and radiologic features and are distinguished primarily by the histopathologic... read more characterized by infiltration of alveoli and alveolar septa with small lymphocytes and varying numbers of plasma cells. Non-necrotizing, poorly formed granulomas may be present but are usually rare and inconspicuous.

The cause is postulated to be an autoimmune disease or a nonspecific response to infection with Epstein-Barr virus Infectious Mononucleosis Infectious mononucleosis is caused by Epstein-Barr virus (EBV, human herpesvirus type 4) and is characterized by fatigue, fever, pharyngitis, and lymphadenopathy. Fatigue may persist weeks or... read more Infectious Mononucleosis , HIV Human Immunodeficiency Virus (HIV) Infection Human immunodeficiency virus (HIV) infection results from 1 of 2 similar retroviruses (HIV-1 and HIV-2) that destroy CD4+ lymphocytes and impair cell-mediated immunity, increasing risk of certain... read more Human Immunodeficiency Virus (HIV) Infection , or other viruses. Evidence of an autoimmune etiology includes its frequent association with Sjögren syndrome Sjögren Syndrome Sjögren syndrome is a relatively common chronic, autoimmune, systemic, inflammatory disorder of unknown cause. It is characterized by dryness of the mouth, eyes, and other mucous membranes due... read more Sjögren Syndrome (25% of cases of LIP) and other disorders (eg, systemic lupus erythematosus Systemic Lupus Erythematosus (SLE) Systemic lupus erythematosus is a chronic, multisystem, inflammatory disorder of autoimmune etiology, occurring predominantly in young women. Common manifestations may include arthralgias and... read more Systemic Lupus Erythematosus (SLE) , rheumatoid arthritis Rheumatoid Arthritis (RA) Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that primarily involves the joints. RA causes damage mediated by cytokines, chemokines, and metalloproteases. Characteristically... read more Rheumatoid Arthritis (RA) , Hashimoto thyroiditis Hashimoto Thyroiditis Hashimoto thyroiditis is chronic autoimmune inflammation of the thyroid with lymphocytic infiltration. Findings include painless thyroid enlargement and symptoms of hypothyroidism. Diagnosis... read more —14% of cases). Evidence of an indirect viral etiology includes frequent association with immunodeficient states (HIV/AIDS, combined variable immunodeficiency, agammaglobulinemia—14% of cases) and findings of Epstein-Barr virus DNA and HIV RNA in lung tissue of patients with LIP. According to this theory, LIP is an extreme manifestation of the normal ability of lymphoid tissue in the lung to respond to inhaled and circulating antigens.

Symptoms and Signs of Lymphocytic Interstitial Pneumonia

In adults, lymphocytic interstitial pneumonia causes symptoms of progressive dyspnea and cough. These manifestations progress over months or, in some cases, years and appear at a mean age of 54. Weight loss, fever, arthralgias, and night sweats occur but are less common.

Examination may reveal crackles. Findings such as hepatosplenomegaly, arthritis, and lymphadenopathy are uncommon and suggest an accompanying or alternative diagnosis.

Diagnosis of Lymphocytic Interstitial Pneumonia

  • High-resolution CT (HRCT)

  • For confirmation, biopsy

Diagnosis of lymphocytic interstitial pneumonia is usually suspected in at-risk patients with compatible symptoms. Imaging tests and sometimes lung biopsy are done.

Chest x-ray shows bibasilar linear reticular or nodular opacities, a nonspecific finding that is present in a number of pulmonary infections. Alveolar opacities, cysts, or both may be present in more advanced disease.

HRCT of the chest is done and helps establish the extent of disease, define the hilar anatomy, and identify pleural involvement. HRCT findings are highly variable. Characteristic findings are centrilobular and subpleural nodules, thickened bronchovascular bundles, nodular ground-glass opacities, and cystic structures.

Marked hypoxemia may occur.

Bronchoalveolar lavage should be done to rule out infection and may reveal an increased number of lymphocytes.

Routine laboratory testing and serum protein electrophoresis (SPEP) are done because about 80% of patients have a serum protein abnormality, most commonly a polyclonal gammopathy and hypogammaglobulinemia, the significance of which is unknown.

Lung biopsy with demonstration of expansion of the alveolar septae due to lymphocytic and other immune cell (plasma cell, immunoblastic, histiocytic) infiltrates is required for diagnosis in adults. Infiltrates appear occasionally along bronchi and vessels but most commonly along alveolar septa. Immunohistochemical staining and flow cytometry must be done on the tissue to distinguish LIP from primary lymphomas. In LIP, the infiltrate is polyclonal (both T and B cells), whereas other lymphomas produce monoclonal infiltrates. Other common findings include germinal centers and multinucleated giant cells with noncaseating granulomas.

Prognosis for Lymphocytic Interstitial Pneumonia

The natural history and prognosis of LIP in adults are poorly understood. Spontaneous resolution, resolution after treatment with corticosteroids or other immunosuppressive drugs, progression to lymphoma, or development of pulmonary fibrosis with respiratory insufficiency may ensue. Five-year survival is 50 to 66%. Common causes of death are infection, development of malignant lymphoma (5%), and progressive fibrosis.

Treatment of Lymphocytic Interstitial Pneumonia

  • Corticosteroids or cytotoxic drugs

Treatment of lymphocytic interstitial pneumonia is with corticosteroids, cytotoxic drugs, or both, but, as with many other causes of interstitial lung diseases, the efficacy of this approach is unknown.

Key Points

  • Lymphocytic interstitial pneumonia is rare overall, but is one of the most common lung disorders in HIV-positive children.

  • Symptoms and signs tend to be nonspecific.

  • Do high-resolution CT, bronchoalveolar lavage, and sometimes lung biopsy.

  • Treat patients with corticosteroids, cytotoxic drugs, or both.

Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read
Test your knowledge
Which of the following is the most common cause of atelectasis?
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID

Also of Interest